Radient Technologies Inc. announced that it has received its Cannabis Research Licence under Health Canada's Cannabis Act and Cannabis Regulations. This license permits Radient to expand its research activities by allowing the controlled administration of cannabis to human subjects to complete a comprehensive evaluation of sensory preferences. A human sensory panel is an extremely valuable tool to include in product development and quality programs. It will now form an integral part of Radient's R&D and product development and innovation activities by including the ability to evaluate cannabis extracts, concentrates, edibles and topicals for reactions of human subjects to the smell, sight, taste and touch at the product development stage. This new tool will improve the inherent quality of cannabis product offerings by complementing the stringent internal manufacturing quality systems currently in place, ensuring that all products continue to meet consumers' expectations. This is in addition to Radient's proprietary MAP continuous extraction process that has proven to generate high recoveries (> 95%) of active compounds from the cannabis plant.